Alain Pralong, Ph.D. Head of Manufacturing Process and Development
Prior to joining AgenTus, Dr. Pralong held a number of roles increasing in seniority at Novartis, Schering-Plough, Roche, Merck-Serono, Crucell, GlaxoSmithKline, Cell Medica, and most recently at AMAL, where he served as Chief Operating Officer.
During his tenure at Cell Medica, Dr. Pralong led the development of cell therapy products for phase II clinical trials in non-Hodgkin and Hodgkin lymphoma.
At AMAL, Dr. Pralong set up external manufacturing networks for phase I clinical studies for a therapeutic cancer vaccine.
Dr. Pralong has been listed in the 100 most influential people in biopharmaceutical industry issued by The Medicine Maker.